PhenoLearn
Description: By targeting cellular resilience, we are pioneering a new way to treat the many diseases that arise from aging.
Fountain Therapeutics Congratulates Co-Founder and Executive Chairman Thomas Rando, M.D., Ph.D., for Prestigious NOMIS Distinguished Scientist Award
Cellular aging is a biological process, which involves pathways that are common among many important physiological processes in our bodies. Degenerative diseases are often caused by deterioration of these processes, resulting from a disruption of these common pathways. This provides us with an opportunity to ameliorate many chronic degenerative diseases by targeting pathways of cellular aging. At Fountain, we use our deep insight into the biology of aging along with our proprietary AI-driven technology — le
learn more
PhenoLearn